Avonex Pen Alternatives Compared
| Avonex Pen (interferon beta-1a) | Kesimpta (ofatumumab) | Copaxone (glatiramer) |
|
|---|
| Avonex Pen (interferon beta-1a) | Kesimpta (ofatumumab) | Copaxone (glatiramer) |
|
|||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Prescription only
Prescribed for Multiple Sclerosis. Avonex Pen may also be used for purposes not listed in this medication guide. |
Prescription only
Prescribed for Multiple Sclerosis. Kesimpta may also be used for purposes not listed in this medication guide. |
Prescription only
Copaxone is a combination of four amino acids that may be given to treat relapsing forms of multiple sclerosis in adults. It has been shown to significantly reduce the number of relapses but may be... View more |
||||||||||||||||||||||||||||||
| More about Avonex Pen (interferon beta-1a) | More about Kesimpta (ofatumumab) | More about Copaxone (glatiramer) | ||||||||||||||||||||||||||||||
| Ratings & Reviews | ||||||||||||||||||||||||||||||||
|
Avonex Pen has an average rating of 8.7 out of 10 from a total of 14 ratings on Drugs.com. 79% of reviewers reported a positive effect, while 0% reported a negative effect. |
Kesimpta has an average rating of 7.0 out of 10 from a total of 97 ratings on Drugs.com. 55% of reviewers reported a positive effect, while 16% reported a negative effect. |
Copaxone has an average rating of 7.5 out of 10 from a total of 135 ratings on Drugs.com. 65% of reviewers reported a positive effect, while 16% reported a negative effect. |
||||||||||||||||||||||||||||||
|
View all 14 reviews |
View all 97 reviews |
View all 135 reviews |
||||||||||||||||||||||||||||||
| Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified. | ||||||||||||||||||||||||||||||||
|
View all side effects |
View all side effects |
View all side effects |
||||||||||||||||||||||||||||||
| Boxed Warnings A boxed warning is the most serious warning from the Food and Drug Administration (FDA) about drug effects that may be dangerous. | ||||||||||||||||||||||||||||||||
|
N/A |
View boxed warnings |
N/A |
||||||||||||||||||||||||||||||
| Drug Class | ||||||||||||||||||||||||||||||||
| Generic Availability Learn more about brand vs generic drugs. | ||||||||||||||||||||||||||||||||
|
N/A |
N/A |
|||||||||||||||||||||||||||||||
| Pricing and Coupons * Prices are without insurance. | ||||||||||||||||||||||||||||||||
|
|
|
||||||||||||||||||||||||||||||
| Dosage Forms | ||||||||||||||||||||||||||||||||
|
|
|
||||||||||||||||||||||||||||||
| Brand Names | ||||||||||||||||||||||||||||||||
| Other interferon beta-1a brands include: Avonex, Avonex Prefilled Syringe, Rebif, Rebif Rebidose | Other ofatumumab brands include: Arzerra | Other glatiramer brands include: Glatopa | ||||||||||||||||||||||||||||||
| Half Life Learn about the half-life of a drug and how it is calculated. | ||||||||||||||||||||||||||||||||
|
3 hours |
1476 hours |
1 hour |
||||||||||||||||||||||||||||||
| CSA Schedule 1 View glossary of CSA terms | ||||||||||||||||||||||||||||||||
|
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||||||||||||||||||||||||
| Pregnancy Category | ||||||||||||||||||||||||||||||||
|
Category C
See the full pregnancy warnings document. |
Category C
See the full pregnancy warnings document. |
Category B
See the full pregnancy warnings document. |
||||||||||||||||||||||||||||||
| Drug Interactions | ||||||||||||||||||||||||||||||||
|
A total of 360 drugs are known to interact with Avonex Pen:
|
A total of 187 drugs are known to interact with Kesimpta:
|
A total of 1 drugs are known to interact with Copaxone:
|
||||||||||||||||||||||||||||||
| Alcohol/Food/Lifestyle Interactions | ||||||||||||||||||||||||||||||||
|
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||||||||||||||||||||||||
| Disease Interactions | ||||||||||||||||||||||||||||||||
|
No known disease interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||||||||||||||||||||||||||
| First Approval Date | ||||||||||||||||||||||||||||||||
|
N/A |
October 26, 2009 |
December 20, 1996 |
||||||||||||||||||||||||||||||
| WADA Class View classifications | ||||||||||||||||||||||||||||||||
|
N/A |
N/A |
N/A |
||||||||||||||||||||||||||||||
| More Information | ||||||||||||||||||||||||||||||||
| Patient Resources | ||||||||||||||||||||||||||||||||
| Professional Resources | ||||||||||||||||||||||||||||||||
|
N/A |
||||||||||||||||||||||||||||||||
| Related Treatment Guide | ||||||||||||||||||||||||||||||||
1 The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
See also:
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.